(Q44607739)

4 December 2017

title

Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma (English)

1 reference

4 December 2017

Docetaxel as Neoadjuvant Chemotherapy in Patients With Advanced Cervical Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

18 March 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

18 March 2024

author name string

Fabrina Bologna

5

1 reference

4 December 2017

Hernán Vicente

6

1 reference

4 December 2017

Alberto Cubero

9

1 reference

4 December 2017

Guillermo Focaccia

10

1 reference

4 December 2017

Guillermo Suttora

11

1 reference

4 December 2017

Mirna Scenna

12

1 reference

4 December 2017

Carlos T. Vallejo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

Mario R. Machiavelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

Juan E. Pérez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

Alberto O. Romero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

Juan A. Lacava

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

Eduardo H. Ortiz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

José M. Boughen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

Bernardo A. Leone

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528074

18 March 2024

language of work or name

1 reference

1 October 2003

1 reference

full work available at URL

4 December 2017

https://journals.lww.com/10.1097/01.coc.0000037109.12434.52

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

American Journal of Clinical Oncology

18 March 2024

published in

1 reference

4 December 2017

volume

26

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

477-482

1 reference

Estimates of the worldwide incidence of eighteen major cancers in 1985.

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Chemotherapy as a palliative treatment in carcinoma of the uterine cervix

18 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma

18 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix

18 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

18 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison

18 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus

18 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer

18 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix

18 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Cisplatin (cis-diamminedichloroplatinum II)

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

18 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

18 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

18 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

18 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Concurrent chemotherapy and radiation: a major advance for women with cervical cancer

18 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Promotion of microtubule assembly in vitro by taxol

18 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Relationships between the structure of taxol analogs and their antimitotic activity

18 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

18 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

18 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Docetaxel: an active drug for squamous cell carcinoma of the head and neck

18 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

18 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

18 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase I trial of Taxotere: five-day schedule

18 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

18 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Reporting results of cancer treatment

18 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Nonparametric Estimation from Incomplete Observations

18 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer

18 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

The importance of dose intensity in chemotherapy of metastatic breast cancer

18 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix

18 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri

18 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN).

18 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

New approaches to high-risk cervical cancer. Advanced cervical cancer

18 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.

18 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/01.COC.0000037109.12434.52

18 March 2024

Identifiers

1 reference

4 December 2017

1 reference